ÀÚ°¡ ¼¼Æ÷ Ä¡·á ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2031³â)
Autologous Cell Therapy Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
»óǰÄÚµå : 1539391
¸®¼­Ä¡»ç : Persistence Market Research
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 155 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,995 £Ü 7,227,000
Unprintable PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ º¹»ç, ÀμⰡ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 7,295 £Ü 10,555,000
PDF & Excel (Multi User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste¿Í ÀμⰡ °¡´ÉÇÕ´Ï´Ù.
US $ 8,495 £Ü 12,291,000
PDF & Excel (Corporate User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste¿Í ÀμⰡ °¡´ÉÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Persistence Market Research´Â ÃÖ±Ù ¼¼°è ÀÚ°¡ ¼¼Æ÷ Ä¡·á ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ º¸°í¼­¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ º¸°í¼­´Â ½ÃÀå ÃËÁø¿äÀÎ, µ¿Çâ, ±âȸ ¹× °úÁ¦¸¦ Æ÷ÇÔÇÑ ÁÖ¿ä ½ÃÀå ¿ªÇÐÀ» öÀúÈ÷ Æò°¡ÇÏ°í ½ÃÀå ±¸Á¶¿¡ ´ëÇÑ ½ÉÃþÀûÀÎ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.

ÁÖ¿ä ÀλçÀÌÆ®

ÀÚ°¡ ¼¼Æ÷ Ä¡·á ½ÃÀå - º¸°í¼­ ¹üÀ§:

ÀÚ°¡ ¼¼Æ÷ Ä¡·á´Â ȯÀÚ ÀÚ½ÅÀÇ ¼¼Æ÷¸¦ Ä¡·á¿¡ »ç¿ëÇÏ´Â °ÍÀ¸·Î ¾Ï, ÀÚ°¡¸é¿ªÁúȯ, ÅðÇ༺ Áúȯ µî ´Ù¾çÇÑ Áúȯ¿¡ Àû¿ëµÉ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀå¿¡´Â Áٱ⼼Æ÷ Ä¡·á, CAR-T ¼¼Æ÷ Ä¡·á, Àç»ýÀÇ·á µî ´Ù¾çÇÑ Ä¡·á¹ýÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ ½ÃÀåÀº º´¿ø, Àü¹® Ŭ¸®´Ð, ¿¬±¸±â°üÀ» ´ë»óÀ¸·Î Çϸç, ȯÀÚ °³°³ÀÎÀÇ Çʿ信 µû¶ó ¸ÂÃãÇü Ä¡·á¹ýÀ» Á¦°øÇÕ´Ï´Ù. ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº ¼¼Æ÷ Ä¡·á ±â¼úÀÇ ¹ßÀü, ¸¸¼ºÁúȯÀÇ Áõ°¡, »õ·Î¿î Ä¡·á Á¢±Ù¹ý¿¡ ´ëÇÑ ¿¬±¸ È®´ëÀÔ´Ï´Ù.

½ÃÀå ÃËÁø¿äÀÎ:

¼¼°è ÀÚ°¡ ¼¼Æ÷ Ä¡·á ½ÃÀåÀº ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í º¹ÀâÇÑ Áúº´À» Ä¡·áÇϱâ À§ÇÑ Ã·´Ü ¼¼Æ÷ Ä¡·áÁ¦ äÅÃÀÌ Áõ°¡ÇÏ´Â µî ¸î °¡Áö ÁÖ¿ä ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¾Ï, ÀÚ°¡¸é¿ªÁúȯ, ÅðÇ༺ ÁúȯÀÇ ¹ßº´·ü Áõ°¡´Â È¿°úÀûÀ̰í Ç¥ÀûÈ­µÈ Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¼¼Æ÷ °¡°ø ±â¼úÀÇ Çâ»ó°ú º¸´Ù Á¤±³ÇÑ ¼¼Æ÷ Á¶ÀÛ ¹æ¹ýÀÇ °³¹ß°ú °°Àº ±â¼ú ¹ßÀüÀº ÀÚ°¡ ¼¼Æ÷ Ä¡·áÀÇ È¿°ú¿Í ¾ÈÀü¼ºÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿¬±¸°³¹ß¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡¿Í À¯¸®ÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©°¡ ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¾ïÁ¦¿äÀÎ:

À¯¸ÁÇÑ ¼ºÀå Àü¸Á¿¡µµ ºÒ±¸Çϰí, ÀÚ°¡ ¼¼Æ÷ Ä¡·á ½ÃÀåÀº ³ôÀº Ä¡·áºñ¿ë, º¹ÀâÇÑ Á¦Á¶ °øÁ¤, ±ÔÁ¦Àû Àå¾Ö¹° µîÀÇ ¹®Á¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ÀÚ°¡ ¼¼Æ÷ Ä¡·áÀÇ °³¹ß ¹× »ý»ê¿¡´Â ¸¹Àº ÅõÀÚ¿Í Àü¹® ÀÎÇÁ¶ó°¡ ÇÊ¿äÇϸç, ÀÌ´Â Á¢±Ù¼º°ú °æÁ¦¼ºÀ» Á¦ÇÑÇÒ ¼ö ÀÖ½À´Ï´Ù. º¹ÀâÇÑ ±ÔÁ¦¿Í ¾ÈÀü¼º°ú À¯È¿¼ºÀ» º¸ÀåÇϱâ À§ÇÑ ¾ö°ÝÇÑ ÀÓ»ó½ÃÇèÀÇ Çʿ伺µµ ½ÃÀå È®´ë¿¡ °É¸²µ¹·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÚ°¡ ¼¼Æ÷ Ä¡·á¿¡ ´ëÇÑ Á¦ÇÑµÈ º¸Çè ȯ±Þ ¿É¼Ç°ú Áٱ⼼Æ÷ ¿¬±¸¿Í °ü·ÃµÈ ÀáÀçÀûÀÎ À±¸®Àû ¿ì·Á´Â ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ±âȸ:

ÀÚ°¡ ¼¼Æ÷ Ä¡·á ½ÃÀåÀº ±â¼ú Çõ½Å, ÀÀ¿ë ºÐ¾ß È®´ë, ÀÇ·á ¼­ºñ½º Á¦°ø ¸ðµ¨ÀÇ ÁøÈ­·Î ÀÎÇØ Å« ¼ºÀå ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ÀΰøÁö´É, ·Îº¿°øÇÐ µî ÷´Ü ±â¼úÀÌ ¼¼Æ÷ 󸮿¡ ÅëÇյǸ鼭 Ä¡·áÀÇ Á¤È®¼º°ú È¿À²¼ºÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ´Ù¾çÇÑ Áúº´¿¡ ´ëÇÑ Àç»ýÀÇ·á¿Í ¸ÂÃãÄ¡·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ½ÃÀå ±â¾÷µé¿¡°Ô »õ·Î¿î ±æÀ» ¿­¾îÁÖ°í ÀÖ½À´Ï´Ù. Àü·«Àû ÆÄÆ®³Ê½Ê, ÷´Ü ¿¬±¸¿¡ ´ëÇÑ ÅõÀÚ, ºñ¿ë È¿À²ÀûÀÎ Ä¡·á¹ý °³¹ßÀº »õ·Î¿î ±âȸ¸¦ Ȱ¿ëÇÏ°í ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù.

º» º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä Áú¹®µé

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå °³¿ä

Á¦3Àå ºÎ°¡°¡Ä¡ ÀλçÀÌÆ®

Á¦4Àå °¡°Ý µ¿Ç⠺м®, 2019-2031³â

Á¦5Àå ¼¼°èÀÇ ÀÚ°¡ ¼¼Æ÷ Ä¡·á ½ÃÀå Àü¸Á : °ú°Å(2019-2023³â) ¹× ¿¹Ãø(2024-2031³â)

Á¦6Àå ¼¼°èÀÇ ÀÚ°¡ ¼¼Æ÷ Ä¡·á ½ÃÀå Àü¸Á : Áö¿ª

Á¦7Àå ºÏ¹ÌÀÇ ÀÚ°¡ ¼¼Æ÷ Ä¡·á ½ÃÀå Àü¸Á : °ú°Å(2019-2023³â) ¹× ¿¹Ãø(2024-2031³â)

Á¦8Àå À¯·´ÀÇ ÀÚ°¡ ¼¼Æ÷ Ä¡·á ½ÃÀå Àü¸Á : °ú°Å(2019-2023³â) ¹× ¿¹Ãø(2024-2031³â)

Á¦9Àå µ¿¾Æ½Ã¾ÆÀÇ ÀÚ°¡ ¼¼Æ÷ Ä¡·á ½ÃÀå Àü¸Á : °ú°Å(2019-2023³â) ¹× ¿¹Ãø(2024-2031³â)

Á¦10Àå ³²¾Æ½Ã¾Æ ¹× ¿À¼¼¾Æ´Ï¾ÆÀÇ ÀÚ°¡ ¼¼Æ÷ Ä¡·á ½ÃÀå Àü¸Á : °ú°Å(2019-2023³â) ¹× ¿¹Ãø(2024-2031³â)

Á¦11Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ ÀÚ°¡ ¼¼Æ÷ Ä¡·á ½ÃÀå Àü¸Á : °ú°Å(2019-2023³â) ¹× ¿¹Ãø(2024-2031³â)

Á¦12Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÀÚ°¡ ¼¼Æ÷ Ä¡·á ½ÃÀå Àü¸Á : °ú°Å(2019-2023³â) ¹× ¿¹Ãø(2024-2031³â)

Á¦13Àå °æÀï »óȲ

Á¦14Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Persistence Market Research has recently released a comprehensive report on the worldwide market for autologous cell therapy. The report provides a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, offering detailed insights into the market structure.

Key Insights:

Autologous Cell Therapy Market - Report Scope:

Autologous cell therapy involves using a patient's own cells for treatment, which can be applied to various medical conditions including cancer, autoimmune disorders, and degenerative diseases. This market includes a range of therapies such as stem cell treatments, CAR-T cell therapies, and regenerative medicine. The market caters to hospitals, specialized clinics, and research institutions, offering tailored therapies based on individual patient needs. Market growth is driven by advancements in cell therapy technologies, increasing prevalence of chronic diseases, and expanding research into novel treatment approaches.

Market Growth Drivers:

The global autologous cell therapy market is propelled by several key factors, including rising awareness about personalized medicine and the increasing adoption of advanced cell therapies for treating complex diseases. The growing incidence of cancers, autoimmune disorders, and degenerative conditions fuels demand for effective and targeted treatments. Technological advancements, such as improved cell processing techniques and the development of more sophisticated cell manipulation methods, enhance the efficacy and safety of autologous therapies. Additionally, increasing investments in research and development and favorable regulatory frameworks are further stimulating market growth.

Market Restraints:

Despite promising growth prospects, the autologous cell therapy market faces challenges related to high treatment costs, complex manufacturing processes, and regulatory hurdles. The development and production of autologous therapies require significant investment and specialized infrastructure, which can limit accessibility and affordability. Regulatory complexities and the need for rigorous clinical trials to ensure safety and efficacy also pose barriers to market expansion. Furthermore, limited reimbursement options for autologous therapies and potential ethical concerns related to stem cell research can impact market growth.

Market Opportunities:

The autologous cell therapy market presents significant growth opportunities driven by technological innovations, expanding applications, and evolving healthcare delivery models. The integration of advanced technologies, such as artificial intelligence and robotics in cell processing, is enhancing treatment precision and efficiency. The increasing focus on regenerative medicine and personalized treatments for various conditions opens new avenues for market players. Strategic partnerships, investment in cutting-edge research, and the development of cost-effective therapies are essential to capitalize on emerging opportunities and drive market growth.

Key Questions Answered in the Report:

Competitive Intelligence and Business Strategy:

Leading players in the global autologous cell therapy market, including Novartis AG, Gilead Sciences, Inc., and Kite Pharma, Inc., focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced cell therapies, such as CAR-T and stem cell-based treatments, catering to diverse therapeutic needs. Collaborations with research institutions, healthcare providers, and regulatory agencies facilitate market access and promote technology adoption. Emphasis on clinical research, evidence-based practice, and patient-centered approaches is crucial to sustaining market leadership in the rapidly evolving autologous cell therapy landscape.

Key Companies Profiled:

Autologous Cell Therapy Industry Segmentation

By Therapy

By Application

By Source

By End-use

By Geographical Regions

Table of Contents

1. Executive Summary

2. Market Overview

3. Value Added Insights

4. Price Trend Analysis, 2019-2031

5. Global Autologous Cell Therapy Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

6. Global Autologous Cell Therapy Market Outlook: Region

7. North America Autologous Cell Therapy Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

8. Europe Autologous Cell Therapy Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

9. East Asia Autologous Cell Therapy Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

10. South Asia & Oceania Autologous Cell Therapy Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

11. Latin America Autologous Cell Therapy Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

12. Middle East & Africa Autologous Cell Therapy Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

13. Competition Landscape

14. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â